Acceleron Pharma Net Tangible Assets

Acceleron Pharma (XLRN) currently reports a net tangible assets of $720M as of September 2021. That compares with $900M in the prior-year period — down 19.8% year over year. Use the charts on this page to explore Acceleron Pharma's net tangible assets history and peer comparisons.

Acceleron Pharma's net tangible assets decreased from $900M to $720M — a 19.8% year-over-year decrease (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acceleron Pharma reported $720M in net tangible assets as of September 2021. That compares with $900M in the prior-year period — down 19.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $720M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acceleron Pharma, and consider following XLRN for alerts when major investors trade the stock.

Acceleron Pharma is classified in the Healthcare sector. On net tangible assets, it currently shows $720M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing XLRN with unrelated industries.